Clinical Trial Update: A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update describes an anxiolytic treatment being studied for improving cognitive function in Alzheimer's disease, with the study status l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Zhejiang Provincial People's Hospital | Conditions: Alzheimer Disease, Cognitive Function | Phase 4 | Status: UNKNOWN